Chen, Y., Shah, N. N., Renteria, A. S., Cutler, C., Jansson, J., Akbari, M., . . . Devine, S. M. (2019). Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood Adv.
Chicago Style CitationChen, Yi-Bin, et al. "Vedolizumab for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation." Blood Adv 2019.
MLA CitationChen, Yi-Bin, et al. "Vedolizumab for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation." Blood Adv 2019.
Warning: These citations may not always be 100% accurate.